Cancer Biology, Toxicology and Alternative Methods Development Go Hand‐in‐Hand
Open Access
- 23 May 2014
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 115 (1) , 50-58
Abstract
Toxicological research faces the challenge of integrating knowledge from diverse fields and novel technological developments generally in the biological and medical sciences. We discuss herein the fact that the multiple facets of cancer research, including discovery related to mechanisms, treatment and diagnosis, overlap many up and coming interest areas in toxicology, including the need for improved methods and analysis tools. Common to both disciplines, in vitro and in silico methods serve as alternative investigation routes to animal studies. Knowledge on cancer development helps in understanding the relevance of chemical toxicity studies in cell models, and many bioinformatics‐based cancer biomarker discovery tools are also applicable to computational toxicology. Robotics‐aided, cell‐based, high‐throughput screening, microscale immunostaining techniques and gene expression profiling analyses are common tools in cancer research, and when sequentially combined, form a tiered approach to structured safety evaluation of thousands of environmental agents, novel chemicals or engineered nanomaterials. Comprehensive tumour data collections in databases have been translated into clinically useful data, and this concept serves as template for computer‐driven evaluation of toxicity data into meaningful results. Future ‘cancer research‐inspired knowledge management’ of toxicological data will aid the translation of basic discovery results and chemicals‐ and materials‐testing data to information relevant to human health and environmental safety.Keywords
This publication has 64 references indexed in Scilit:
- InCroMAP: integrated analysis of cross-platform microarray and pathway dataBioinformatics, 2012
- Molecular signatures from omics data: From chaos to consensusBiotechnology Journal, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- Toward interoperable bioscience dataNature Genetics, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive modelsNature Biotechnology, 2010
- Modeling sample variables with an Experimental Factor OntologyBioinformatics, 2010
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- CEBS Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics dataNucleic Acids Research, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006